Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of purification method of brexpiprazole hydrochloride

A purification method, hydrochloride technology, applied in the field of purification of benzo[B]thiophene compounds, can solve problems such as cumbersome operation, unsuitable for large-scale industrial production, difficult to remove by-products, etc.

Active Publication Date: 2021-11-23
BEIJING WINSUNNY PHARMA CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The reaction of the above-mentioned step I produces a relatively large amount of by-products which are difficult to separate. Although purification by column chromatography is used to increase the purity of 1-benzo[b]thiophen-4-yl-piperazine hydrochloride, it is difficult to purify even by column chromatography. By-products are completely removed, and the by-products contained in 1-benzo[b]thiophen-4-yl-piperazine hydrochloride inevitably reduce the purity of Brexpiprazole in the subsequent step II
The method described in the patent CN103717587 also needs to be purified by column chromatography to obtain high-purity Brexpiprazole. However, column chromatography purification is not suitable for large-scale industrial production due to its cumbersome operation and high cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of purification method of brexpiprazole hydrochloride
  • A kind of purification method of brexpiprazole hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] To 24 g of crude Brexpiprazole were added 480 ml of ethanol and 24 ml of acetic acid, and the mixture was stirred under reflux to dissolve the crude product. Add 6.5g of hydrochloric acid and cool to 10°C. Heated to reflux again and cooled to 7°C. Crystals were separated and washed with 24 ml of ethanol. The separated crystals were dried at 60°C to obtain 25.3 g of brexpiprazole hydrochloride in a yield of 97.3%.

[0026] Add 20g of Brexpiprazole hydrochloride, 200ml of dimethyl sulfoxide and 1g of activated carbon into the reaction flask, raise the temperature to about 60°C, stir under temperature control for 0.5 hours, filter, transfer the filtrate to the reaction flask, raise the temperature to about 60°C again, and add 200ml Ethyl acetate was stirred under temperature control for 0.5 hours, cooled to room temperature, crystallized for 3 hours, filtered, and the filter cake was dried to obtain 17.8 g of high-purity Brexpiprazole hydrochloride with a yield of 89%. ...

Embodiment 2

[0029] To 24 g of crude Brexpiprazole were added 450 ml of methanol and 20 ml of acetic acid, and the mixture was stirred under reflux to dissolve the crude product. Add 6.7g of hydrochloric acid and cool to 10°C. Heated to reflux again and cooled to 7°C. Crystals were separated and washed with 25 ml of methanol. The separated crystals were dried at 60°C to obtain 25.0 g of brexpiprazole hydrochloride in a yield of 96.2%.

[0030] Add 20g of Brexpiprazole hydrochloride, 220ml of dimethyl sulfoxide and 1.4g of activated carbon into the reaction flask, raise the temperature to about 40°C, stir under temperature control for 0.5 hours, filter, transfer the filtrate to the reaction flask, raise the temperature to about 60°C again, add 66ml of ethanol was stirred under temperature control for 0.5 hours, cooled to 10°C, crystallized for 3 hours, filtered, and the filter cake was dried to obtain 17.2g of high-purity Brexpiprazole hydrochloride with a yield of 86%.

[0031]15 g of B...

Embodiment 3

[0033] To 24 g of crude Brexpiprazole were added 500 ml of tetrahydrofuran and 25 ml of formic acid, and the mixture was stirred under reflux to dissolve the crude product. Add 6.5g of hydrochloric acid and cool to 10°C. Heated to reflux again and cooled to 7°C. Crystals were separated and washed with 25 ml of tetrahydrofuran. The separated crystals were dried at 60°C to obtain 24.8 g of brexpiprazole hydrochloride in a yield of 95.4%.

[0034] Add 20g of Brexpiprazole hydrochloride, 200ml of dimethylformamide and 1.8g of activated carbon into the reaction flask, raise the temperature to about 50°C, stir under temperature control for 0.5 hours, filter, transfer the filtrate to the reaction flask, raise the temperature to about 80°C again, add 250ml of isopropanol was stirred under temperature control for 0.5 hours, cooled to 20°C, crystallized for 3 hours, filtered, and the filter cake was dried to obtain 16.6g of high-purity Brexpiprazole hydrochloride with a yield of 83%. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for purifying brexpiprazole hydrochloride. The crude product of brexpiprazole hydrochloride is recrystallized under the action of positive solvent and anti-solvent to obtain high-purity brexpiprazole hydrochloride. The method can effectively remove the difficult-to-separate impurities. The purification route does not require column chromatography for purification, conventional solvents and equipment can meet the purification requirements, has a good purification effect, and is suitable for large-scale industrial production.

Description

technical field [0001] The invention relates to a method for purifying benzo[B]thiophene compounds, in particular to a method for purifying Brexpiprazole hydrochloride. Background technique [0002] Brexpiprazole is used to treat schizophrenia, depression and other diseases. It is the first dopamine, partial 5-HT1A receptor agonist and 5-HT2A receptor antagonist compound developed by Otsuka Pharmaceutical Company. It is a clinically significant compound multitargeted antipsychotic drugs. In terms of schizophrenia, Brexpiprazole is as effective as aripiprazole, but it is more superior in improving negative symptoms, cognitive function and depression. Brexpiprazole has unique pharmacological targeting. Compared with traditional typical antipsychotic drugs and atypical antipsychotic drugs, it has a wider therapeutic range and fewer side effects, and has excellent tolerance and safety. The chemical name of Brexpiprazole is: 7-(4-(4-(benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D409/12
CPCC07D409/12
Inventor 吴朋伟林国良韩杰张晓斌王占伟耿玉先王岩
Owner BEIJING WINSUNNY PHARMA CO LTD